BRANT WANG to Cystadenocarcinoma, Serous
This is a "connection" page, showing publications BRANT WANG has written about Cystadenocarcinoma, Serous.
Connection Strength
0.790
-
Aneuploidy Landscape in Precursors of Ovarian Cancer. Clin Cancer Res. 2024 02 01; 30(3):600-615.
Score: 0.211
-
Morphologic and Molecular Heterogeneity of High-grade Serous Carcinoma Precursor Lesions. Am J Surg Pathol. 2024 Apr 01; 48(4):475-486.
Score: 0.211
-
Spatial Transcriptomic Analysis of Ovarian Cancer Precursors Reveals Reactivation of IGFBP2 during Pathogenesis. Cancer Res. 2022 12 16; 82(24):4528-4541.
Score: 0.195
-
Evaluation of normal-sized ovaries associated with primary peritoneal serous carcinoma for possible precursors of ovarian serous carcinoma. Gynecol Oncol. 2007 Jul; 106(1):201-6.
Score: 0.066
-
Characterization of active mitogen-activated protein kinase in ovarian serous carcinomas. Clin Cancer Res. 2004 Oct 01; 10(19):6432-6.
Score: 0.055
-
Genomic landscape and evolutionary trajectories of ovarian cancer precursor lesions. J Pathol. 2019 05; 248(1):41-50.
Score: 0.037
-
Molecular genetic analysis of ovarian serous cystadenomas. Lab Invest. 2004 Jun; 84(6):778-84.
Score: 0.014